Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.58−0.05 (-3.07%)
Close on Nov 13, 2026Market cap $11.09MP/E –Yield –
Vyome cash
Cash and short-term investments held at the end of each period.
Vyome's cash was $6.96M at Sep 30, 2026. For fiscal 2025 it was $4.98M, up 4789.2% from the year before. Over ten years it grew -8.8% a year on average. The highest annual figure on record is $75.48M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.98M | +4789.2% |
| FY2024 | Dec 31, 2024 | $101.90K | +512.1% |
| FY2023 | Dec 31, 2023 | $16.65K | -99.6% |
| FY2022 | Dec 31, 2022 | $3.96M | -82.7% |
| FY2021 | Dec 31, 2021 | $22.82M | +658.7% |
| FY2020 | Dec 31, 2020 | $3.01M | +0.7% |
| FY2019 | Dec 31, 2019 | $2.99M | -87.4% |
| FY2018 | Dec 31, 2018 | $23.74M | -46.5% |
| FY2017 | Dec 31, 2017 | $44.40M | -41.2% |
| FY2016 | Dec 31, 2016 | $75.48M | +502.3% |
| FY2015 | Dec 31, 2015 | $12.53M | +81.6% |
| FY2014 | Dec 31, 2014 | $6.90M | +173.1% |
| FY2013 | Dec 31, 2013 | $2.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.96M | +21.9% |
| Q2 FY2026 | Jun 30, 2026 | $7.89M | +1957.3% |
| Q1 FY2026 | Mar 31, 2026 | $8.80M | +14969.0% |
| Q4 FY2025 | Dec 31, 2025 | $4.98M | +4789.2% |
| Q3 FY2025 | Sep 30, 2025 | $5.71M | +11577.5% |
| Q2 FY2025 | Jun 30, 2025 | $383.39K | +3094.9% |
| Q1 FY2025 | Mar 31, 2025 | $58.37K | -97.6% |
| Q4 FY2024 | Dec 31, 2024 | $101.90K | +512.1% |
| Q3 FY2024 | Sep 30, 2024 | $48.87K | -96.8% |
| Q2 FY2024 | Jun 30, 2024 | $12.00K | -99.7% |
| Q1 FY2024 | Mar 31, 2024 | $2.48M | -72.7% |
| Q4 FY2023 | Dec 31, 2023 | $16.65K | -99.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.55M | -75.2% |
| Q2 FY2023 | Jun 30, 2023 | $4.67M | -59.6% |
| Q1 FY2023 | Mar 31, 2023 | $9.08M | -41.2% |
| Q4 FY2022 | Dec 31, 2022 | $3.96M | -82.7% |
| Q3 FY2022 | Sep 30, 2022 | $6.25M | -78.7% |
| Q2 FY2022 | Jun 30, 2022 | $11.54M | -71.3% |
| Q1 FY2022 | Mar 31, 2022 | $15.46M | +694.5% |
| Q4 FY2021 | Dec 31, 2021 | $22.82M | +658.7% |
| Q3 FY2021 | Sep 30, 2021 | $29.29M | +1436.1% |
| Q2 FY2021 | Jun 30, 2021 | $40.21M | +2451.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.95M | -78.2% |
| Q4 FY2020 | Dec 31, 2020 | $3.01M | +0.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.91M | -90.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.58M | -88.3% |
| Q1 FY2020 | Mar 31, 2020 | $8.92M | -63.9% |
| Q4 FY2019 | Dec 31, 2019 | $2.99M | -87.4% |
| Q3 FY2019 | Sep 30, 2019 | $19.38M | -34.7% |
| Q2 FY2019 | Jun 30, 2019 | $13.51M | -46.4% |
| Q1 FY2019 | Mar 31, 2019 | $24.68M | -26.3% |
| Q4 FY2018 | Dec 31, 2018 | $23.74M | -46.5% |
| Q3 FY2018 | Sep 30, 2018 | $29.67M | -44.4% |
| Q2 FY2018 | Jun 30, 2018 | $25.21M | -58.5% |
| Q1 FY2018 | Mar 31, 2018 | $33.48M | -49.8% |
| Q4 FY2017 | Dec 31, 2017 | $44.40M | -41.2% |
| Q3 FY2017 | Sep 30, 2017 | $53.37M | – |
| Q2 FY2017 | Jun 30, 2017 | $60.73M | – |
| Q1 FY2017 | Mar 31, 2017 | $66.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $75.48M | – |
See a number that looks wrong?